These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10591669)

  • 1. Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients.
    Beaulieu AJ; Gohh RY; Han H; Hakas D; Jacques PF; Selhub J; Bostom AG
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2918-21. PubMed ID: 10591669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
    Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Bagley P; Massy ZA; Jacques PF; Dworkin L; Selhub J
    Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
    Bostom AG; Shemin D; Bagley P; Massy ZA; Zanabli A; Christopher K; Spiegel P; Jacques PF; Dworkin L; Selhub J
    Circulation; 2000 Jun; 101(24):2829-32. PubMed ID: 10859289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients.
    Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Jacques PF; Dworkin L; Selhub J
    Transplantation; 2000 May; 69(10):2128-31. PubMed ID: 10852611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
    van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
    J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial.
    Scott TM; Rogers G; Weiner DE; Livingston K; Selhub J; Jacques PF; Rosenberg IH; Troen AM
    J Prev Alzheimers Dis; 2017; 4(3):174-182. PubMed ID: 29182708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
    Yango A; Shemin D; Hsu N; Jacques PF; Dworkin L; Selhub J; Bostom AG
    Kidney Int; 2001 Jan; 59(1):324-7. PubMed ID: 11135086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with different doses of folic acid in haemodialysis patients: effects on folate distribution and aminothiol concentrations.
    Arnadottir M; Gudnason V; Hultberg B
    Nephrol Dial Transplant; 2000 Apr; 15(4):524-8. PubMed ID: 10727548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia and assessment of its associated factors in renal transplant recipients: a single-center study in northern Iran.
    Monfared A; Azimi SZ; Kazemnezhad E; Khosravi M; Lebadi M; Mirzajani E; Ashtiani MN
    Transplantation; 2014 Jul; 98(1):66-71. PubMed ID: 24978036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
    Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
    Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
    Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
    Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.
    Bostom AG; Gohh RY; Liaugaudas G; Beaulieu AJ; Han H; Jacques PF; Dworkin L; Rosenberg IH; Selhub J
    Atherosclerosis; 1999 Jul; 145(1):221-4. PubMed ID: 10428313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation.
    Koyama K; Usami T; Takeuchi O; Morozumi K; Kimura G
    Nephrol Dial Transplant; 2002 May; 17(5):916-22. PubMed ID: 11981084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
    Dierkes J; Domröse U; Bosselmann KP; Neumann KH; Luley C
    J Ren Nutr; 2001 Apr; 11(2):67-72. PubMed ID: 11295026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of plasma total homocysteine levels in Korean chronic renal transplant recipients.
    Han H; Dwyer JT; Selhub J; Jacques PF; Park JH; Kim YS; Bang BK; Bostom AG
    J Ren Nutr; 2000 Oct; 10(4):202-7. PubMed ID: 11070148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
    Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
    Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.
    Ghandour H; Bagley PJ; Shemin D; Hsu N; Jacques PF; Dworkin L; Bostom AG; Selhub J
    Kidney Int; 2002 Dec; 62(6):2246-9. PubMed ID: 12427152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.